DogStem RSSAuthorisedThis medicine is authorised for use in the European Unionequine umbilical cord-derived mesenchymal stem cellsMedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on DogStemApplication under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine DogStem Active substance equine umbilical cord-derived mesenchymal stem cells International non-proprietary name (INN) or common name equine umbilical cord-derived mesenchymal stem cells Pharmacotherapeutic group Other drugs for disorders of the musculo-skeletal system Authorisation details EMA product number EMEA/V/C/005829 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for DogStemAdoptedReference Number: EMA/CVMP/576246/2022 English (EN) (124.62 KB - PDF)First published: 17/06/2022ViewNews on DogStemMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 202217/06/2022This page was last updated on 08/02/2024Share this page